Neuro2a cells endogenously express cannabinoid type 1 (CB1) receptors. CB1 stimulation with HU210 activated ERK and induced the transcription factor Krox-24. A functional MEK-ERK pathway is an important requirement for CB1-mediated Krox-24 induction as blockade of MEK signaling by UO126 reduces both basal and CB1-mediated activation of Krox-24. CB1 receptor stimulation did not activate either JNK or p38 MAPK pathways or the pro-proliferation phosphatidylinositol 3-kinase (PI3K)-Akt pathway. However, serum removal or blockade of PI3K signaling by LY294002 transiently stimulated basal Krox-24 expression and increased CB1-mediated induction of Krox-24. This was consistent with a transient increase in pMEK, pERK, and pCREB levels following PI3K blockade. These data demonstrate that CB1-mediated activation of the Krox-24 transcription factor is negatively regulated through the PI3K-Akt pathway and reveals several points of signaling cross-talk between these two important kinase pathways.In the brain the cannabinoid type 1 (CB1) 2 receptor is largely responsible for mediating the effects of endocannabinoids and cannabinoid drugs like âŹ9-tetrahydrocannabinol (THC). Detailed neuroanatomical and ultrastructural studies have demonstrated that CB1 receptors are localized pre-synaptically in populations of GABA-ergic and glutamatergic neurons in specific brain regions, including the basal ganglia, cerebellum, hippocampus, and cortex (1-8).A major physiological function of the cannabinoid system at these synapses is to regulate the release of various neurotransmitters (8 -10). Consequently, there has been much interest in understanding the signaling pathways that mediate both the short and long term effects of endocannabinoids in these brain regions. Several in vivo studies have shown a robust up-regulation of c-Fos and Krox-24 in specific neuronal populations within the striatum (11, 12) and hippocampus (10, 12, 13) following cannabinoid treatment. In an elegant study by Marsicano et al. (10), the CB1 receptors were knocked out specifically within the hippocampal glutamatergic principal neurons resulting in elevated glutamate toxicity leading to severe seizures and death. The CB1 activation of the ERK pathway, c-Fos, and Krox-24 were strongly implicated by the authors in the protection against glutamate toxicity (10).As described above Krox-24 and c-Fos are physiologically regulated by CB1 in specific neuronal cells and are likely involved in the long term neuronal changes induced by cannabinoids. Krox-24 has been associated with important biological functions such as the stabilization of long lasting long-term potentiation (14, 15), cell differentiation (16 -18), and as a cell survival or death signal in neuronal cells (18,19). There is also evidence that Krox-24 is involved in the regulation of specific neurotransmitters and receptors (20 -22). Although a wealth of research has been conducted into CB1 receptor signaling, there is very little known about the precise molecular pathways involved in the coupling of CB1 to Kro...